美国医疗保险受益人群中光动力疗法的可及性和费用趋势，2012-2017 年。
Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017.
机构信息
Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
Department of Dermatology, University of Connecticut School of Medicine, Farmington.
出版信息
JAMA Dermatol. 2020 Sep 1;156(9):1021-1022. doi: 10.1001/jamadermatol.2020.2427.
Abstract
This cross-sectional study evaluates the geographical variation in the availability of photodynamic therapy for the Medicare population in the United States and characterizes the temporal trends of photodynamic therapy cost and use from 2012 to 2017.
摘要
本横断面研究评估了美国 Medicare 人群中光动力疗法的可及性在地理上的差异，并描述了 2012 年至 2017 年光动力疗法成本和使用的时间趋势。
相似文献
1
Trends in the Access and Cost of Photodynamic Therapy Among Medicare Beneficiaries in the United States, 2012-2017.美国医疗保险受益人群中光动力疗法的可及性和费用趋势，2012-2017 年。
JAMA Dermatol. 2020 Sep 1;156(9):1021-1022. doi: 10.1001/jamadermatol.2020.2427.
2
Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.外用氨基酮戊酸光动力疗法（MAL-PDT）治疗光化性角化病和基底细胞癌的临床疗效及成本效益的真实世界实践研究
Eur J Dermatol. 2008 Sep-Oct;18(5):539-46. doi: 10.1684/ejd.2008.0469. Epub 2008 Aug 8.
3
Rural-urban differences in surgical procedures for Medicare beneficiaries.医疗保险受益人的手术程序中的城乡差异。
Arch Surg. 2011 May;146(5):579-83. doi: 10.1001/archsurg.2010.306. Epub 2011 Jan 17.
4
Access to care for rural Medicare beneficiaries.农村医疗保险受益人的医疗服务获取情况。
J Rural Health. 2000 Winter;16(1):31-42. doi: 10.1111/j.1748-0361.2000.tb00434.x.
5
Medicare minus choice: the impact of HMO withdrawals on rural Medicare beneficiaries.医疗保险（医保）选择减少：健康维护组织（HMO）退出对农村医保受益人的影响。
Health Aff (Millwood). 2002 May-Jun;21(3):192-9. doi: 10.1377/hlthaff.21.3.192.
6
Rural-urban disparities in the utilization of mental health inpatient services in China: the role of health insurance.中国城乡在心理健康住院服务利用方面的差异：医疗保险的作用。
Int J Health Econ Manag. 2018 Dec;18(4):377-393. doi: 10.1007/s10754-018-9238-z. Epub 2018 Mar 27.
7
Use and Cost of Actinic Keratosis Destruction in the Medicare Part B Fee-for-Service Population, 2007 to 2015.2007 年至 2015 年 Medicare 部分 B 按服务收费人群中光化性角化病破坏的使用和成本。
JAMA Dermatol. 2018 Nov 1;154(11):1281-1285. doi: 10.1001/jamadermatol.2018.3086.
8
Cost disparities for outpatient dermatology visits among medicare beneficiaries in urban and rural regions of the United States.美国城乡医疗保险受益人的门诊皮肤科就诊费用差异。
Arch Dermatol Res. 2024 Jul 23;316(7):484. doi: 10.1007/s00403-024-03223-6.
9
Missing the handoff: post-hospitalization follow-up care among rural Medicare beneficiaries with diabetes.交接缺失：农村糖尿病医疗保险受益人的出院后随访护理
Rural Remote Health. 2012;12:2097. Epub 2012 Jul 20.
10
2011 Medicare payment changes part 1: physicians who perform wound care services and procedures.2011 年医疗保险支付变更第 1 部分：进行伤口护理服务和程序的医生。
Adv Skin Wound Care. 2011 Apr;24(4):157-9. doi: 10.1097/01.ASW.0000396299.27043.96.
引用本文的文献
1
Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.光化性角化病局部治疗随机对照试验的系统评价。
Arch Dermatol Res. 2024 Mar 18;316(4):108. doi: 10.1007/s00403-024-02839-y.
2
Photodynamic Therapy in Treating a Subset of Basal Cell Carcinoma: Strengths, Shortcomings, Comparisons with Surgical Modalities, and Potential Role as Adjunctive Therapy.光动力疗法治疗基底细胞癌亚类：优势、不足、与手术方式的比较，以及作为辅助治疗的潜在作用。
Am J Clin Dermatol. 2024 Jan;25(1):99-118. doi: 10.1007/s40257-023-00829-w. Epub 2023 Dec 2.
3
Assessment of Photodynamic Therapy Services Performed Among Medicare Beneficiaries from 2018 to 2019.
J Clin Aesthet Dermatol. 2022 Nov;15(11):37-39.
本文引用的文献
1
Access to injectable biologic medications by medicare beneficiaries: geographic distribution of US dermatologist prescribers.医疗保险受益人获取注射用生物药物的情况：美国皮肤科医生处方者的地理分布
J Dermatolog Treat. 2019 May;30(3):237-239. doi: 10.1080/09546634.2018.1508819. Epub 2018 Sep 12.
2
Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015.美国医疗保险受益人群 2000 至 2015 年光疗应用趋势。
J Am Acad Dermatol. 2018 Oct;79(4):672-679. doi: 10.1016/j.jaad.2018.03.018. Epub 2018 Mar 21.
3
Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.美国 2012 年人群中非黑色素瘤皮肤癌（角质形成细胞癌）的发病率估计。
JAMA Dermatol. 2015 Oct;151(10):1081-6. doi: 10.1001/jamadermatol.2015.1187.
4
2013 NCHS Urban-Rural Classification Scheme for Counties.2013年国家卫生统计中心县域城乡分类方案
Vital Health Stat 2. 2014 Apr(166):1-73.
5
Management of field change in actinic keratosis.
Br J Dermatol. 2007 Dec;157 Suppl 2:21-4. doi: 10.1111/j.1365-2133.2007.08268.x.
6
Skin cancer is among the most costly of all cancers to treat for the Medicare population.对于医疗保险人群来说，皮肤癌是所有癌症中治疗成本最高的癌症之一。
J Am Acad Dermatol. 2003 Mar;48(3):425-9. doi: 10.1067/mjd.2003.186.
Zotero 插件